Correction to “M2 Tumor Associate Macrophage- (TAM-) Derived lncRNA HISLA Promotes EMT Potential in Bladder Cancer”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBladder and Urothelial Cancer Treatments · Cancer-related molecular mechanisms research · Immune cells in cancer
Y. Guo, Z. Li, W. Sun, et al., “M2 Tumor Associate Macrophage‐(TAM‐) Derived lncRNA HISLA Promotes EMT Potential in Bladder Cancer,” Journal of Oncology 2022 (2022): 8268719, https://doi.org/10.1155/2022/8268719.
In the Results section, Figure 6(d) is incorrect. During the preparation of the manuscript, Figure 6(c) was mistakenly uploaded in duplicate. The correct Figure 6 is shown below.
We apologize for this error.